MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ringdahl, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ringdahl, B.

Selectivity of partial agonists related to oxotremorine based on differences in muscarinic receptor reserve between the guinea pig ileum and urinary bladder

B Ringdahl

The muscarinic effects of analogs of oxotremorine were compared on strips of the guinea pig ileum and urinary bladder. In a series of eight analogs, full or nearly full contractile responses compared to carbachol were observed on the ileum. On the bladder, the analogs were full agonists, partial agonists, or competitive antagonists. Although EC50 values estimated on the bladder were 10- to 20-fold greater than those obtained on the ileum, the dissociation constant and relative efficacy of each agonist were similar in the two tissues, as were dissociation constants of competitive antagonists including pirenzepine. The ability to discriminate between responses in the ileum and bladder was related to intrinsic efficacy. Highly efficacious compounds such as carbachol and oxotremorine-M were full agonists in both tissues, although less potent on the bladder. Compounds having intermediate intrinsic efficacy, e.g., oxotremorine, were partial agonists on the bladder, whereas BM 5, having low intrinsic efficacy, was a competitive antagonist. These results suggest a mechanism, based on tissue differences in receptor reserve, by which selectivity may be achieved among muscarinic stimulants, even in the absence of distinct subtypes of muscarinic receptors.

Volume 31, Issue 4, pp. 351-356, 04/01/1987
Copyright © 1987 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
J. M. Loudon, S. M. Bromidge, F. Brown, M. S. G. Clark, J. P. Hatcher, J. Hawkins, G. J. Riley, G. Noy, and B. S. Orlek
SB 202026: A Novel Muscarinic Partial Agonist with Functional Selectivity for M1 Receptors
J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 1059 - 1068.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
M. Srinivas, J. C. Shryock, D. M. Dennis, S. P. Baker, and L. Belardinelli
Differential A1 Adenosine Receptor Reserve for Two Actions of Adenosine on Guinea Pig Atrial Myocytes
Mol. Pharmacol., October 1, 1997; 52(4): 683 - 691.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1987 by the American Society for Pharmacology and Experimental Therapeutics